Run-in period

From WikiMD's Medical Encyclopedia

(Redirected from Washout period)

Run-in period is a term used in clinical trials to describe a preliminary period before the actual study begins. This period is used to stabilize the participants' conditions, eliminate the effects of previous treatments, and establish a baseline for comparison. The run-in period can also be used to assess the participants' compliance and suitability for the study.

Purpose[edit]

The main purpose of the run-in period is to ensure that all participants start the trial in a similar state. This helps to reduce the variability in the results and increase the accuracy of the findings. The run-in period can also be used to screen out participants who are unlikely to comply with the trial protocol or who experience adverse effects from the treatment.

Types of Run-in Periods[edit]

There are several types of run-in periods, including:

  • Washout period: This is a period during which participants stop taking any previous treatments to eliminate their effects. This is particularly important in trials of new drugs, where the effects of the previous treatment could interfere with the results.
  • Placebo run-in period: During this period, all participants are given a placebo to establish a baseline for comparison. This can also help to screen out participants who are likely to drop out of the trial or who experience placebo effects.
  • Open-label run-in period: In this type of run-in period, all participants are given the active treatment to assess their response and tolerance. This can help to identify participants who are likely to benefit from the treatment and those who may experience adverse effects.

Criticisms[edit]

While the run-in period can improve the accuracy of clinical trials, it has also been criticized for potentially biasing the results. For example, by excluding participants who do not respond to the treatment during the run-in period, the trial may overestimate the effectiveness of the treatment. There are also ethical concerns about giving participants a placebo or withdrawing their current treatment during the run-in period.

See also[edit]

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia


Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.